Published in J Am Med Dir Assoc on November 01, 2015
Task complexity and location specific changes of cortical thickness in executive and salience networks after working memory training. Neuroimage (2016) 1.02
Computer-Based Cognitive Training for Executive Functions after Stroke: A Systematic Review. Front Hum Neurosci (2016) 0.78
Computer-Based Cognitive Training in Aging. Front Aging Neurosci (2016) 0.78
Cortical Thickness Changes Correlate with Cognition Changes after Cognitive Training: Evidence from a Chinese Community Study. Front Aging Neurosci (2016) 0.76
Brain training improves recovery after stroke but waiting list improves equally: A multicenter randomized controlled trial of a computer-based cognitive flexibility training. PLoS One (2017) 0.75
Small Acute Benefits of 4 Weeks Processing Speed Training Games on Processing Speed and Inhibition Performance and Depressive Mood in the Healthy Elderly People: Evidence from a Randomized Control Trial. Front Aging Neurosci (2016) 0.75
Barriers, Benefits, and Beliefs of Brain Training Smartphone Apps: An Internet Survey of Younger US Consumers. Front Hum Neurosci (2016) 0.75
Use of the Internet as a prevention tool against cognitive decline in normal aging. Clin Interv Aging (2016) 0.75
Brain training games help older adults perform essential tasks, study finds. BMJ (2015) 0.75
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses. Lancet Neurol (2015) 1.64
Don't use antipsychotics routinely to treat agitation and aggression in people with dementia. BMJ (2014) 1.47
Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic. J Psychopharmacol (2014) 1.17
A complementary peptide approach applied to the design of novel semaphorin/neuropilin antagonists. J Neurochem (2005) 0.92
The importance of pain management in older people with dementia. Br Med Bull (2014) 0.85
Dementia in Down's syndrome. Lancet Neurol (2016) 0.85
Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial. Health Technol Assess (2015) 0.80
Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis. J Am Med Dir Assoc (2015) 0.77
Role of the extended MAPT haplotype in the worsening of psychotic symptoms and treatment response in Alzheimer disease. J Am Med Dir Assoc (2014) 0.77
Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry (2016) 0.76
Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations. Health Technol Assess (2017) 0.76
A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD). J Am Med Dir Assoc (2014) 0.75
The assessment and management of pain in patients with dementia in hospital settings: a multi-case exploratory study from a decision making perspective. BMC Health Serv Res (2016) 0.75
Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches. Evid Based Med (2015) 0.75
The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs. Evid Based Med (2014) 0.75
Taking a positive spin: preserved initiative and performance of everyday activities across mild Alzheimer's, vascular and mixed dementia. Int J Geriatr Psychiatry (2016) 0.75
Treatment of childhood anxiety disorder in the context of maternal anxiety disorder: a randomised controlled trial and economic analysis. Health Technol Assess (2015) 0.75
Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial. Int J Geriatr Psychiatry (2016) 0.75